Literature DB >> 8625592

Heterogeneous survival rates for isolated skeletal metastases from melanoma.

D K DeBoer1, H S Schwartz, S Thelman, V H Reynolds.   

Abstract

In this study, the authors examine the survivorship of individuals who constitute the small subset of patients with Stage IV melanoma who present with their first and only detectable metastasis to the skeleton. One thousand two hundred six patients were identified with primary melanoma at the authors' institution since 1962. There were 14 patients with isolated (solitary) skeletal metastases. Survival was calculated by Kaplan-Meier technique. The survival rate for any individual with an isolated metastasis to the axial skeleton was 0. Three of 8 patients with melanoma metastases to the appendicular skeleton are alive at 18, 25, and 52 months after Stage IV detection. A statistically significant prolonged latency period (initial diagnosis to Stage IV) in the appendicular group compared with the axial group contributed to their significant survival rate advantage. The melanoma literature strongly supports the complete resection of soft tissue metastatic foci. These data support this concept and extend it to include isolated skeletal metastases. The mechanisms by which axial and appendicular skeletal metastases occur are significantly different. This difference manifests itself as a survival advantage for the appendicular group and warrants an aggressive surgical approach for these individuals.

Entities:  

Mesh:

Year:  1996        PMID: 8625592     DOI: 10.1097/00003086-199602000-00038

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  6 in total

1.  Operative management of metastatic melanoma in bone may require en bloc resection of disease.

Authors:  Jeffrey E Krygier; Valerae O Lewis; Christopher P Cannon; Robert L Satcher; Bryan S Moon; Patrick P Lin
Journal:  Clin Orthop Relat Res       Date:  2014-07-03       Impact factor: 4.176

2.  [Metastatic malignant choroidal melanoma: a case report about 18 years with palliative operative treatment].

Authors:  T Prietzel; I Haferkorn; A Macher; E Schumann; G von Salis-Soglio; T Aigner
Journal:  Orthopade       Date:  2009-03       Impact factor: 1.087

3.  Malignant melanoma and bone resorption.

Authors:  Y S Lau; A Sabokbar; H Giele; V Cerundolo; W Hofstetter; N A Athanasou
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

4.  Metastatic malignant melanoma of the conjunctiva: a case report.

Authors:  Nikolaos Manidakis; Ioannis Polyzois; Euaggelos Tsialogiannis; Maria Marples; Andrew Boon; Eleftherios Tsiridis
Journal:  Cases J       Date:  2009-02-04

5.  Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan.

Authors:  Kuo-Yuan Huang; Chrong-Reen Wang; Rong-Sen Yang
Journal:  BMC Musculoskelet Disord       Date:  2007-07-25       Impact factor: 2.362

6.  Complications of bone metastases from malignant melanoma.

Authors:  Jamal Zekri; Maria Marples; Dominic Taylor; Kiran Kandukurti; Lucy McParland; Janet E Brown
Journal:  J Bone Oncol       Date:  2017-08-18       Impact factor: 4.072

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.